NA
IH

NewEdge Advisors’s iHuman IH Stock Holding History

NewEdge Advisors’s Portfolio IH Stock Details IH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-211
Closed -$624 – 3560
2023
Q2 		$624 Buy
+211
New +$654 ﹤0.01% 3297

Other funds holding IH

APA
Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

NewEdge Advisors's IH Position: Q3 2023 in Review

NewEdge Advisors sold out of iHuman (IH) in Q3 2023, closing a stake of 211 shares — an estimated $624 sold.

NewEdge Advisors first reported a position in IH in Q2 2023 and held it in 1 quarter. The position peaked at $624 in Q2 2023. 8 funds tracked by Wall St. Rank hold IH as of Q3 2023.

  • NewEdge Advisors reported no remaining iHuman position as of Q3 2023 after selling out during the quarter.
  • NewEdge Advisors sold 211 iHuman shares in Q3 2023, an estimated $624.
  • NewEdge Advisors first reported a position in iHuman in Q2 2023 and held it in 1 quarter.
  • NewEdge Advisors's iHuman position peaked at $624 in Q2 2023.
  • 8 funds tracked by Wall St. Rank held iHuman as of Q3 2023.

Based on NewEdge Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.